Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Sponsor: Janssen Research & Development, LLC
Summary
The purpose of this study is to evaluate the efficacy and safety of talquetamab in participants with relapsed or refractory multiple myeloma at the recommended Phase 2 dose(s) (RP2Ds) (Part 3).
Official title: A Phase 1/2, First-in-Human, Open-Label, Dose Escalation Study of Talquetamab, a Humanized GPRC5D x CD3 Bispecific Antibody, in Subjects With Relapsed or Refractory Multiple Myeloma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
510
Start Date
2021-02-01
Completion Date
2029-03-30
Last Updated
2026-03-17
Healthy Volunteers
No
Conditions
Interventions
Talquetamab
Talquetamab will be administered SC until disease progression.
Locations (77)
University of Alabama Birmingham
Birmingham, Alabama, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
City of Hope
Duarte, California, United States
Memorial Healthcare System
Hollywood, Florida, United States
Emory University Winship Cancer Institute
Atlanta, Georgia, United States
University of Chicago
Chicago, Illinois, United States
Norton Cancer Institute
Louisville, Kentucky, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Washington University School Of Medicine
St Louis, Missouri, United States
NYU Langone Health
New York, New York, United States
Mount Sinai Medical Center
New York, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
Providence Portland Medical Center
Portland, Oregon, United States
Tennessee Oncology
Nashville, Tennessee, United States
UZ Antwerpen
Edegem, Belgium
UZ Leuven
Leuven, Belgium
CHU de Liège - Domaine Universitaire du Sart Tilman
Liège, Belgium
UCL - Saint Luc
Woluwe-Saint-Lambert, Belgium
Peking University Third Hospital
Beijing, China
Sun Yat Sen University Cancer Center
Guangzhou, China
The 1St Affiliated Hospital of Medical College Zhejiang University
Hangzhou, China
First Affiliated Hospital SooChow University
Suzhou, China
Institute of Hematology & Blood Disease Hospital Chinese Academy of Medical Science
Tianjin, China
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
The First Affiliated Hospital of Xian Jiaotong University
Xi'an, China
CHU Henri Mondor
Créteil, France
Hospices Civils de Lyon HCL
Lyon, France
CHU de Montpellier Hopital Saint Eloi
Montpellier, France
C.H.U. Hotel Dieu - France
Nantes, France
CHU de Bordeaux - Hospital Haut-Leveque
Pessac, France
Pôle IUC Oncopole CHU
Toulouse, France
Charite Campus Benjamin Franklin
Berlin, Germany
Universitaetsklinikum Heidelberg
Heidelberg, Germany
Universitaetsklinikum Muenster
Münster, Germany
Universitatsklinikum Wurzburg
Würzburg, Germany
Rambam Medical Center
Haifa, Israel
Carmel Medical Center
Haifa, Israel
Hadassah Medical Center
Jerusalem, Israel
Sheba Medical Center
Ramat Gan, Israel
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Kameda Medical Center
Chiba, Japan
Fukuoka University Hospital
Fukuoka, Japan
Ogaki Municipal Hospital
Gifu, Japan
Teine Keijinkai Hospital
Hokkaido, Japan
Kobe City Medical Center General Hospital
Kobe, Japan
Dokkyo Medical University Saitama Medical Center
Koshigaya, Japan
Kumamoto University Hospital
Kumamoto, Japan
Kurashiki Central Hospital
Kurashiki, Japan
National Hospital Organization Matsumoto Medical Center
Matsumoto, Japan
National Hospital Organization Okayama Medical Center
Okayama, Japan
Japanese Red Cross Osaka Hospital
Osaka, Japan
National Hospital Organization Hiroshima-Nishi Medical Center
Ōtake, Japan
Iwate Medical University Hospital
Shiwa-gun, Japan
VU Medisch Centrum
Amsterdam, Netherlands
UMCU
Utrecht, Netherlands
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut BadawczyOddz w Gliwicach
Gliwice, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu
Poznan, Poland
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
Warsaw, Poland
Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu
Wroclaw, Poland
Chonnam National University Hwasun Hospital
Jeollanam-do, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
The Catholic University of Korea Seoul St Marys Hospital
Seoul, South Korea
Hosp. Univ. Germans Trias I Pujol
Badalona, Spain
Hosp Univ Vall D Hebron
Barcelona, Spain
Inst. Cat. Doncologia-H Duran I Reynals
Barcelona, Spain
Hosp Univ Fund Jimenez Diaz
Madrid, Spain
Hosp. Univ. 12 de Octubre
Madrid, Spain
Hosp. Univ. Virgen de La Arrixaca
Murcia, Spain
Clinica Univ. de Navarra
Pamplona, Spain
Hosp. Quiron Madrid Pozuelo
Pozuelo de Alarcón, Spain
Hosp Clinico Univ de Salamanca
Salamanca, Spain
Hosp. Univ. Marques de Valdecilla
Santander, Spain
Hosp. Virgen Del Rocio
Seville, Spain